Earnings · US stocks
Oscar Health, Inc. Class A (OSCR) earnings
Oscar Health, Inc. Class A published its quarterly report on 2026-11-05. The stock moved -8.67% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-05
- Result
- Great
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -5.71% | — |
| 3 days | -8.67% | — |
| 7 days | -11.76% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 5 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +4.38%).
| Published | EPS YoY | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|
| 2026-11-05 | — | 0.49 | +382.60% | -8.67% | — | — |
| 2026-08-06 | — | 1.10 | +189.17% | -8.10% | +6.21% | +7.14% |
| 2026-05-06 | +125.00% | 2.07 | +88.18% | +18.78% | +57.58% | +55.21% |
| 2026-02-10 | — | -1.24 | -34.58% | +8.29% | -4.98% | +0.90% |
| 2025-11-06 | — | -0.53 | +8.65% | -14.21% | -13.09% | -12.93% |
| 2025-08-06 | -545.00% | -0.89 | -6.46% | +11.87% | +28.58% | +23.61% |
| 2025-05-07 | +48.40% | 0.92 | +13.93% | +30.91% | +43.61% | +36.70% |
| 2025-02-04 | — | -0.62 | -6.49% | -3.80% | -15.90% | -10.15% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
Stock valuations: OSCR · Stock news: OSCR
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.